易明医药
(002826)
| 流通市值：19.82亿 | | | 总市值：21.47亿 |
| 流通股本：1.76亿 | | | 总股本：1.91亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 227,892,039.74 | 194,177,483.67 | 260,480,491.38 | 385,855,732.02 |
| 应收票据及应收账款 | 86,620,276.62 | 104,418,273.17 | 44,356,340.48 | 38,285,617.41 |
| 其中：应收票据 | 202,395.99 | 299,217.82 | 173,700 | 9,131,590.43 |
| 应收账款 | 86,417,880.63 | 104,119,055.35 | 44,182,640.48 | 29,154,026.98 |
| 预付款项 | 6,328,287.81 | 22,640,758.35 | 6,123,212.17 | 976,621.42 |
| 其他应收款合计 | 3,958,153.2 | 3,795,647.43 | 4,150,915.4 | 5,372,018.69 |
| 存货 | 39,648,652.02 | 33,862,829.59 | 40,396,718.93 | 58,968,753.01 |
| 其他流动资产 | 214,401.71 | 1,120,144.24 | 174,142.03 | 211,581.68 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 524,661,811.1 | 490,015,136.45 | 505,681,820.39 | 489,670,324.23 |
| 非流动资产: | | | | |
| 长期股权投资 | 41,692,322.3 | 42,652,631.21 | 42,561,001.26 | 42,567,473.78 |
| 固定资产 | 336,974,927.1 | 340,374,418.77 | 344,097,611.93 | 349,154,247.92 |
| 在建工程 | 7,543,471.33 | 6,832,258.94 | 1,131,245.03 | - |
| 无形资产 | 21,758,630.74 | 23,076,752.84 | 24,489,334.88 | 25,907,444.36 |
| 商誉 | 16,668,928.89 | 16,668,928.89 | 16,668,928.89 | 16,668,928.89 |
| 递延所得税资产 | 4,064,589.08 | 3,857,504.71 | 3,643,633.73 | 3,512,158.67 |
| 其他非流动资产 | 120,000 | 269,275 | 269,275 | 263,025 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 428,822,869.44 | 433,731,770.36 | 432,861,030.72 | 438,073,278.62 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 953,484,680.54 | 923,746,906.81 | 938,542,851.11 | 927,743,602.85 |
| 流动负债: | | | | |
| 短期借款 | 8,280,000 | 11,000,000 | 11,000,000 | 11,010,561.11 |
| 应付票据及应付账款 | 151,786,589.31 | 120,604,050.87 | 113,783,355.5 | 106,042,931.08 |
| 应付账款 | 151,786,589.31 | 120,604,050.87 | 113,783,355.5 | 106,042,931.08 |
| 合同负债 | 1,866,447.62 | 3,052,821.09 | 1,415,740.5 | 3,510,131.42 |
| 应付职工薪酬 | 8,852,731.42 | 7,491,270.7 | 7,999,735.22 | 11,205,572.96 |
| 应交税费 | 10,322,328.09 | 7,471,630.51 | 12,204,213.22 | 5,217,082.47 |
| 其他应付款合计 | 27,396,053.94 | 31,378,999.67 | 31,150,758.1 | 33,637,469.81 |
| 其他流动负债 | 242,397.16 | 396,866.69 | 184,046.24 | 456,317.06 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 208,746,547.54 | 181,395,639.53 | 177,737,848.78 | 171,080,065.91 |
| 非流动负债: | | | | |
| 递延收益 | 5,976,867.93 | 6,178,233.39 | 6,379,598.85 | 6,604,315.46 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 5,976,867.93 | 6,178,233.39 | 6,379,598.85 | 6,604,315.46 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 214,723,415.47 | 187,573,872.92 | 184,117,447.63 | 177,684,381.37 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 190,677,750 | 190,677,750 | 190,677,750 | 190,677,750 |
| 资本公积 | 232,661,362.96 | 232,661,362.96 | 232,661,362.96 | 232,661,362.96 |
| 减:库存股 | 50,025,670.68 | 50,025,670.68 | 24,506,692.01 | - |
| 其他综合收益 | -249,215.43 | 557,509.59 | 342,102.61 | 296,573.71 |
| 专项储备 | 5,353,781.4 | 4,660,042.74 | 3,877,200.46 | 3,100,583.4 |
| 盈余公积 | 20,860,834.15 | 20,860,834.15 | 20,860,834.15 | 20,860,834.15 |
| 未分配利润 | 333,639,724.85 | 331,466,494 | 325,319,740.9 | 297,420,661.35 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 732,918,567.25 | 730,858,322.76 | 749,232,299.07 | 745,017,765.57 |
| 少数股东权益 | 5,842,697.82 | 5,314,711.13 | 5,193,104.41 | 5,041,455.91 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 738,761,265.07 | 736,173,033.89 | 754,425,403.48 | 750,059,221.48 |
| 负债和股东权益合计 | 953,484,680.54 | 923,746,906.81 | 938,542,851.11 | 927,743,602.85 |
| 公告日期 | 2024-10-30 | 2024-08-16 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |